Pfiz­er scores an 'A' on gen­der and racial pay eq­ui­ty re­port, while Bio­gen flunks

The on­go­ing pan­dem­ic has on­ly ex­ac­er­bat­ed racial and gen­der pay gaps across the board, ac­cord­ing to Ar­ju­na Cap­i­tal and Proxy Im­pact’s lat­est score­card. And while bio­phar­ma dar­ling Pfiz­er has scored it­self an A on the pay eq­ui­ty front, it looks like Bio­gen’s re­port card could spell out even more trou­ble for the em­bat­tled biotech.

Bio­gen was one of 24 com­pa­nies to re­ceive an F on Ar­ju­na and Proxy’s fifth an­nu­al racial and gen­der pay score­card. This year’s score­card looked at 57 ma­jor US com­pa­nies, and Pfiz­er was one of sev­en — in­clud­ing Mas­ter­card, Star­bucks and Adobe — at the top of the class. Dis­ney, Gold­man Sachs, Wal­mart and oth­ers joined Bio­gen in re­ceiv­ing fail­ing grades.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN